Related Experiment Video
Updated: Jun 2, 2026
12:10
Retzius-Sparing Robot-Assisted Radical Prostatectomy
Published on: May 19, 2022
Continuation and satisfaction of reversible contraception
Jeffrey F Peipert1, Qiuhong Zhao, Jenifer E Allsworth
1From the Division of Clinical Research, Department of Obstetrics and Gynecology, Washington University in St. Louis School of Medicine, St. Louis, Missouri.
Obstetrics and Gynecology
|April 22, 2011
Summary
Long-acting reversible contraception, including IUDs and implants, shows higher satisfaction and continuation rates after 12 months compared to oral contraceptive pills. These highly effective methods are recommended as first-line options.
Area of Science:
- Reproductive Health
- Contraception
- Public Health
Background:
- The Contraceptive CHOICE Project aimed to promote long-acting reversible contraception (LARC) and reduce unintended pregnancies.
- Understanding user satisfaction and continuation is crucial for effective contraceptive method selection.
- Comparison between LARC and traditional methods like oral contraceptive pills (OCPs) provides valuable insights.
Purpose of the Study:
- To estimate 12-month satisfaction and continuation rates for intrauterine device (IUD) and implant users.
- To compare these rates with women using oral contraceptive pills (OCPs).
- To evaluate the effectiveness of LARC methods within a real-world setting.
Main Methods:
- Analysis of 12-month follow-up data from 4,167 participants in a prospective cohort study.
- Participants were offered contraception at no cost for 3 years.
- Data collected via telephone surveys regarding contraceptive method choice, satisfaction, and continuation.
Main Results:
- LARC methods were chosen by 68% of participants (levonorgestrel IUD 45%, copper IUD 10%, implant 13%).
- 12-month continuation rates were significantly higher for LARC users (86%) compared to OCP users (55%).
- Satisfaction rates mirrored continuation, with over 80% satisfaction for IUDs versus 54% for OCPs.
Conclusions:
- Intrauterine devices (IUDs) and subdermal implants demonstrate superior 12-month satisfaction and continuation rates.
- LARC methods offer the highest contraceptive efficacy, supporting their recommendation as first-line options.
- Findings support the promotion of LARC to improve contraceptive adherence and reduce unintended pregnancies.
Related Concept Videos
01:22Birth Control Methods
Vasectomy is a surgical form of male sterilization that involves severing and sealing the vasa deferentia, preventing sperm from mixing with semen during ejaculation. Because a vasectomy does not impact the testes' ability to produce testosterone, hormone levels, libido, and sexual function generally remain unchanged. While vasectomy is highly effective in preventing pregnancy, with a success rate near 99.85%, rare cases of recanalization (spontaneous reconnection) can occur. Although vasectomy...
01:21Intrauterine Drug Delivery Systems
Controlled-release systems for intravaginal and intrauterine drug delivery have been developed primarily for the administration of contraceptive steroid hormones. These delivery routes circumvent first-pass hepatic metabolism, thereby enhancing bioavailability and allowing for reduced systemic dosages compared to oral administration. Such approaches contribute to improved therapeutic efficacy and patient compliance, particularly in long-term contraceptive regimens.Intravaginal Drug Delivery...
01:26Oral Drug Delivery Systems: Continuous-Release Systems
Continuous-release drug delivery systems offer a strategic approach to maintaining therapeutic drug levels over extended periods following oral administration. By modulating the release rate of active pharmaceutical ingredients, these systems minimize fluctuations in plasma concentrations, which enhances clinical efficacy and reduces the need for frequent dosing. Such characteristics make them particularly advantageous in managing chronic diseases where patient adherence and stable drug...
01:30Continuous Renal Replacement Therapy
Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...
01:27Ovarian Cycle
The menstrual cycle includes a critical component known as the ovarian cycle, which undergoes two main phases each month—the follicular phase and the luteal phase. The follicular phase is variable and averaging around 14 days. Ovulation, triggered by a surge in luteinizing hormone (LH), marks the transition between the two phases. The second phase, the luteal phase, is relatively consistent, lasting approximately 14 days, and is marked by the activity of the corpus luteum. While a cycle length...
01:26Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in critically...